Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 547 participants.
Also called NCT01193218
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 547 participants
- Registry
-
NCT01193218
-
- Other papers using this trial's data
- Efficacy and safety of empagliflozin monotherapy for 52 weeks in Japanese patients with type 2 diabetes: a randomized, double-blind, parallel-group study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01193218. Randomized; double masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-06 (actual). Results posted on 2014-06-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Placebo (low dose)
- Intervention (Drug)
- Placebo (low dose)
- Intervention (Drug)
- Placebo (mid dose)
- Intervention (Drug)
- Placebo (high dose)
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- Placebo (mid dose)
- Intervention (Drug)
- Placebo (high dose)
- Intervention (Drug)
- Placebo (high dose)
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- Placebo (mid dose)
- Intervention (Drug)
- Placebo (high dose)
- Intervention (Drug)
- Placebo (low dose)
- Intervention (Drug)
- Placebo (low dose)
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- Placebo (mid dose)
- Lead sponsor
- Boehringer Ingelheim
- Collaborator
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01193218- Content hash
e612e3321550c6c725997ad5e5d572eccd79cb691351e84dbe4af129ad9975e6